title: No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients.
authors: Department of Infectious Diseases, Leiden University Medical Center, The Netherlands.
authors: E F
authors: EF
authors: Schippers
authors: P W
authors: PW
authors: Hugen
authors: J
authors: J
authors: den Hartigh
authors: D M
authors: DM
authors: Burger
authors: R M
authors: RM
authors: Hoetelmans
authors: L G
authors: LG
authors: Visser
authors: F P
authors: FP
authors: Kroon
mesh_terms: D000962:Antimalarials / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D019469:Indinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D008288:Malaria / Q000517:prevention & control; D015767:Mefloquine / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D019888:Nelfinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000962:Antimalarials; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019888:Nelfinavir; D015767:Mefloquine